Immune and Inflammatory Diseases Working Party (IIWP)

The European Medicines Agency's (EMA) Immune and Inflammatory Diseases Working Party (IIWP) was set up by the Committee for Medicinal Products for Human Use (CHMP) to carry out specific tasks related to rheumatology and immunology (allergy, transplant and primary immunodeficiencies), pulmonology, gastroenterology, hepatology, nephrology, dermatology and urology.

The working party's tasks include:

• preparing, reviewing and updating guidelines and concept papers on working party related matters;
• European and international co-operation relating to working party activities;
• liaising with interested parties, such as industry, patient organisations and healthcare professional organisations;
• providing trainings and workshops to assessors;
• providing product related support upon request from EMA Committees and the Scientific Advice Working Party.

The working party's name was changed from Rheumatology and Immunology Working Party in February 2026.

Mandate, rules of procedure and work programme

Mandate, objectives, and rules of procedure for working parties under the quality, non-clinical, methodology, clinical and veterinary domains

Reference Number: EMA/299541/2025

Consolidated 3-year work plan for the clinical domain

Reference Number: EXT/31963/2026

Composition

The working party is composed of five to nine experts from Member States, selected from the list of European experts and nominated by members of the CHMP. Experts are chosen on the basis of the best and available expertise needed for the working party to deliver its commitments.

The current members are listed below, in alphabetical order of surname. Their declarations of interests are available in the European experts list: 

• European experts

Members

• Caroline Auriche-Benichou (Chair)
• Andreas Bonertz
• Karoline Buhre
• Hrefna Gudmundsdottir
• Frank Holtkamp
• Karin Janssen van Doorn
• Milica Mitrevski
• Agnieszka Przybyszewska
• Karolina Törneke (Vice-Chair)
• Anna Vikerfors